Document Detail


Vagal cardiac function and arterial blood pressure stability.
MedLine Citation:
PMID:  11668046     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was designed to investigate the importance of vagal cardiac modulation in arterial blood pressure (ABP) stability before and after glycopyrrolate or atropine treatment. Changes in R-R interval (RRI) and ABP were assessed in 10 healthy young (age, 22 +/- 1.8 yr) volunteers during graded lower body negative pressure (LBNP) before and after muscarinic cholinergic (MC) blockade. Transient hypertension was induced by phenylephrine (1 microg/kg body wt), whereas systemic hypotension was induced by bilateral thigh cuff deflation after a 3-min suprasystolic occlusion. Power spectral densities of systolic [systolic blood pressure (SBP)] and diastolic ABP variability were examined. Both antimuscarinic agents elicited tachycardia similarly without significantly affecting baseline ABP. The increase in SBP after phenylephrine injection (+14 +/- 2 mmHg) was significantly augmented with atropine (+26 +/- 2 mmHg) or glycopyrrolate (+27 +/- 3 mmHg) and associated with a diminished reflex bradycardia. The decrease in SBP after cuff deflation (-9.2 +/- 1.2 mmHg) was significantly greater after atropine (-15 +/- 1 mmHg) or glycopyrrolate (-14 +/- 1 mmHg), with abolished reflex tachycardia. LBNP significantly decreased both SBP and RRI. However, after antimuscarinic agents, the reduction in SBP was greater (P < 0.05) and was associated with less tachycardia. Antimuscarinic agents reduced (P < 0.05) the low-frequency (LF; 0.04-0.12 Hz) power of ABP variability at rest. The LF SBP oscillation was significantly augmented during LBNP, which was accentuated (P < 0.05) after antimuscarinic agents and was correlated (r = -0.79) with the decrease in SBP. We conclude that antimuscarinic agents compromised ABP stability by diminishing baroreflex sensitivity, reflecting the importance of vagal cardiac function in hemodynamic homeostasis. The difference between atropine and glycopyrrolate was not significant.
Authors:
D W Wray; K J Formes; M S Weiss; A H O-Yurvati; P B Raven; R Zhang; X Shi
Related Documents :
19852796 - Suggestive linkage detected for blood pressure related traits on 2q and 22q in the popu...
18509346 - Macro and microvasculature in hypertension: therapeutic aspects.
10466476 - Evaluation of the potential interaction between nacl and prostaglandin inhibition in el...
20383856 - Improved management of intradialytic hypotension (idh) using vitamin e-bonded polysulfo...
2708236 - Response of normal subjects to inspiratory resistive unloading.
11583396 - Control of symptoms in patients with meniere's disease using middle ear pressure applic...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of physiology. Heart and circulatory physiology     Volume:  281     ISSN:  0363-6135     ISO Abbreviation:  Am. J. Physiol. Heart Circ. Physiol.     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-10-22     Completed Date:  2001-12-05     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100901228     Medline TA:  Am J Physiol Heart Circ Physiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  H1870-80     Citation Subset:  IM; S    
Affiliation:
Department of Integrative Physiology and Cardiovascular Research Institute, University of North Texas Health Science Center, Fort Worth, Texas 76107, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Agonists / administration & dosage
Adult
Atropine / administration & dosage
Baroreflex / drug effects,  physiology*
Blood Pressure / drug effects,  physiology*
Female
Glycopyrrolate / administration & dosage
Heart Rate / drug effects,  physiology
Humans
Lower Body Negative Pressure
Male
Muscarinic Antagonists / administration & dosage
Phenylephrine / administration & dosage
Vagus Nerve / physiology*
Valsalva Maneuver
Grant Support
ID/Acronym/Agency:
AG-14219/AG/NIA NIH HHS; HL-45547/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Muscarinic Antagonists; 51-55-8/Atropine; 59-42-7/Phenylephrine; 596-51-0/Glycopyrrolate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tetrahydrobiopterin, a cofactor for NOS, improves endothelial dysfunction during chronic alcohol con...
Next Document:  Enhanced sympathoexcitatory and pressor responses to central Na+ in Dahl salt-sensitive vs. -resista...